Utilization of peptides as active ingredients for slimming
A method of using proteins of the SIRT family or of polypeptide or peptide fragments of SIRT proteins as an active ingredient for slimming, alone or in combination with at least one other active agent, in a cosmetic composition or for the preparation of a pharmaceutical and/or dermatological composition. The invention also includes the use of the peptides for treatment of cellulite and/or used to decrease, eliminate or prevent excess fat beneath the skin.
1. A cosmetic, pharmaceutical and/or dermatological composition for reducing excess fat deposits beneath the skin, and/or treating cellulite and/or treating the orange-peel skin effect, comprising:
at least one isolated peptide from the sirtuins (SIRT) family as an active sliming agent, alone or in combination with at least one other active agent; and a cosmetic, pharmaceutical and/or dermatological acceptable medium, wherein said at least one isolated peptide is Gly Leu Tyr Asp Asn Leu Glu (SEQ ID NO: 5), and wherein said at least one isolated peptide has at least one functional group protected by a protecting group formed by an acylation or an acetylation of the amino-terminal end, or an amidation or an esterification of the carboxy-terminal end, or both.
2. The composition according to claim 1 , further comprising a cosmetically acceptable lipolytic agent.
3. The composition according to claim 2 , wherein the lipolytic agent is selected from the group consisting of caffeine, acephyllin, nicotinate of xanthinol, diniprophyllin, diprophyllin, etamiphyllin, etophyllin, proxyphyllin, pentophyllin, propentophyllin, pyridophyllin, bamiphyllin, theophylline, and theobromin.
4. The composition according to claim 1 , wherein the at least one isolated peptide is present in the composition in a concentration between around 0.005 and 500 ppm.
5. The composition according to claim 1 , wherein the at least one isolated peptide is first solubilized in one or more cosmetically or pharmaceutically acceptable solvent selected from the group consisting of water, ethanol, propylene glycol, glycerol, butylene glycol, dipropylene glycol, ethoxylated or propoxylated diglycols, cyclical polyols, vaseline, a vegetable oil, and mixtures thereof.
6. The composition according to claim 1 , wherein the at least one isolated peptide is first solubilized in a cosmetic or pharmaceutical vector or a mineral support.
7. The composition according to claim 1 , wherein the at least one isolated peptide is fixed to a cosmetically or pharmaceutically acceptable vector.
8. The composition according to claim 1 , wherein the at least one isolated peptide is in a galenical form adapted for application on the skin, the mucous membranes, the lips and/or the hair selected from the group consisting of aqueous solutions, water-alcohol solutions, oily solutions, oil-in-water emulsions, water-in-oil emulsions, or multiple emulsions, suspensions, shampoos, sticks, sprays and powders.
9. A cosmetic, pharmaceutical and/or dermatological composition for reducing fat deposits beneath the skin, and/or treating cellulite and/or treating the orange-peel skin effect, comprising:
at least one isolated peptide from the SIRT family as an active slimming agent, alone or in combination with at least one other active agent;
a cosmetic, pharmaceutical and/or dermatological acceptable medium; and
a cosmetically acceptable lipolytic agent, wherein said at least one isolated peptide is Gly Leu Tyr Asp Asn Leu Glu (SEQ ID NO: 5).
10. The composition according to claim 9 , wherein the lipolytic agent is selected from the group consisting of caffeine, acephyllin, nicotinate of xanthinol, diniprophyllin, diprophyllin, etamiphyllin, etophyllin, proxyphyllin, pentophyllin, propentophyllin, pyridophyllin, bamiphyllin, theophylline, and theobromin.
11. The composition according to claim 9 , wherein the at least one isolated peptide has at least one functional group protected by a protecting group formed by an acylation or an acetylation of the amino-terminal end, or an amidation or an esterification of the carboxy-terminal end, or both.
12. The composition according to claim 9 , wherein the at least one isolated peptide is present in the composition in a concentration between around 0.005 and 500 ppm.
13. The composition according to claim 9 , wherein the at least one isolated peptide is first solubilized in one or more cosmetically or pharmaceutically acceptable solvent selected from the group consisting of water, ethanol, propylene glycol, glycerol, butylene glycol, dipropylene glycol, ethoxylated or propoxylated diglycols, cyclical polyols, vaseline, a vegetable oil, and mixtures thereof.
14. The composition according to claim 9 , wherein the at least one isolated peptide is first solubilized in a cosmetic or pharmaceutical vector or a mineral support.
15. The composition according to claim 9 , wherein the at least one isolated peptide is fixed to a cosmetically or pharmaceutically acceptable vector.
16. The composition according to claim 9 , wherein the at least one isolated peptide is in a galenical form adapted for application on the skin, the mucous membranes, the lips and/or the hair selected from the group consisting of aqueous solutions, water-alcohol solutions, oily solutions, oil-in-water emulsions, water-in-oil emulsions, or multiple emulsions, suspensions, shampoos, sticks, sprays and powders.